Items Tagged ‘recurrent’

April 9, 2018

Rubraca® Approved as Maintenance Treatment of Recurrent Ovarian Cancer

By

CancerConnect News: Rubraca® (rucaparib) has been approved for the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in a complete or partial response to platinum-based chemotherapy. Biomarker testing is not required for patients to be prescribed Rubraca in this maintenance treatment indication. About Rubraca® Rubraca® is […]

View full entry

Tags: cancer treatment, News, ovarian, Ovarian Cancer, poly ADP-ribose polymerase (PARP) inhibitor, recurrent, Rubraca, treatment